Victoria Grosu

Solutions for
- - - Aiosyn develops software solutions that use state-of-the-art computational pathology technology. Our AI-powered pathology algorithms are integrated in standard pathology workflows to enable diagnostics and clinical studies anywhere and anytime.
- - - Clinical Diagnostics
      
      We develop algorithms that improve the digital pathology workflow and certified clinical diagnostic algorithms that augment pathologists.
    - Learn more
  - - Life Sciences
      
      We support CROs and biopharma with AI-powered solutions to identify novel pathology-based biomarkers that can accelerate drug development.
    - Learn more
AI Applications
- - - We specialize in deep learning solutions for pathologists, focusing on cancer and chronic kidney disease biomarkers. Our AI-powered technology improves the digital pathology workflow and facilitates informed decision-making in drug development and clinical diagnostics.
- - - Automated Quality Control
      
      We provide an AI-powered solution for automated quality control of digital histology slides in the pathology workflow.
    - Learn more
  - - Mitotic figure counting
      
      We provide an AI-powered solution to aid clinical and research labs with the identification of mitotic figures in H&E sections.
    - Learn more
  - - NephroPath platform
      
      Aiosyn’s NephroPath platform harnesses AI-powered computational pathology algorithms that provide objective quantification of kidney lesion scores.
    - Learn more
Kidney Analysis Services
News & Resources
About

Victoria Grosu

Victoria is a Marketing & Communications Assistant at Aiosyn. She is currently studying for a BSc in Food Technology at Van Hall Larenstein. She found her passion in Marketing and is now helping Aiosyn in our mission to empower pathologists with AI-powered pathology algorithms.

Victoria enjoys cooking, reading, and can often be found at the gym.

Aiosyn develops software solutions that use state-of-the-art computational pathology technology. Our AI-powered pathology algorithms are integrated in standard pathology workflows to enable diagnostics and clinical studies anywhere and anytime.

Clinical Diagnostics

Life Sciences

We specialize in deep learning solutions for pathologists, focusing on cancer and chronic kidney disease biomarkers. Our AI-powered technology improves the digital pathology workflow and facilitates informed decision-making in drug development and clinical diagnostics.

Automated Quality Control

Mitotic figure counting

NephroPath platform

Victoria Grosu

MARKETING & COMMUNICATIONS ASSISTANT

Victoria Grosu

More articles from this author

Behind the scenes of pathology AI innovation – Blazej Dolicki’s insights into training, validation, deployment, and beyond

Discover the clinical performance results of Aiosyn Mitosis Breast at ECDP 2024

Explore the clinical performance insights of Aiosyn Mitosis Breast at USCAP 2024

Time to go digital? Navigating the pathology transition from microscopes to whole slide images

Prepare for the future: AI is changing the landscape of pathology

How automated quality control of whole slide images can increase the efficiency of clinical and research pathology workflows

The digital revolution in pathology: the power of AI in computational pathology

Aiosyn develops software solutions that use state-of-the-art computational pathology technology. Our AI-powered pathology algorithms are integrated in standard pathology workflows to enable diagnostics and clinical studies anywhere and anytime.

Clinical Diagnostics

Life Sciences

We specialize in deep learning solutions for pathologists, focusing on cancer and chronic kidney disease biomarkers. Our AI-powered technology improves the digital pathology workflow and facilitates informed decision-making in drug development and clinical diagnostics.

Automated Quality Control

Mitotic figure counting

NephroPath platform